Abstract
SummarySera from 267 infants, children, and adults living in 2 markedly different eco-logic settings, New Guinea and the United States, were examined for presence of neutralizing antibodies to monkey myxovirus SV5 and monkey adenovirus SV20. SV20 neutralizing antibody in titers of 1:10 to 1:160 were present in New Guinea in 70% of ½-to 5-year olds; in 72% of 6- to 18-year olds; and in 78% of adults. This antibody was absent in the U. S. in individuals in the ½-to 5-year old age group, but was present in titers of 1:10 to 1:80 in 33% of 6- to 18-year olds and in 22% of adults. None of the New Guinea sera and only 8% of the U. S. sera possessed SV5 neutralizing antibody. These data suggest the possibility that SV5 and SV20, or agents antigenically related to them, might be infectious for man.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
